2162-3279

Brain and Behavior

Wiley (John Wiley & Sons)

Health Score

0 Excellent

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 1375 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact1375 DOIs
2

Add abstracts to 423 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact423 DOIs
3

Deposit reference lists for 370 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact370 DOIs

DOIs for this ISSN

Showing the top 5 of 5135 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 A systematic review of reviews on the prevalence of anxiety… (10.1002/brb3.497)
ORCID
70.84 681
2 <i>N</i>‐acetylcysteine (NAC) in neurological disorders: mec… (10.1002/brb3.208)
ORCID
64.58 382
3 Contemporary use and practice of electroconvulsive therapy w… (10.1002/brb3.37)
ORCID
63.00 330
4 The highly sensitive brain: an fMRI study of sensory process… (10.1002/brb3.242)
ORCID
61.06 276
5 An update on immunopathogenesis, diagnosis, and treatment of… (10.1002/brb3.362)
ORCID
60.86 271
6 Prescription stimulants in individuals with and without atte… (10.1002/brb3.78)
ORCID
57.42 197
7 Single‐subject morphological brain networks: connectivity ma… (10.1002/brb3.448)
ORCID
57.20 193
8 Chemotherapy‐induced neuropathies—a growing problem for pati… (10.1002/brb3.558)
ORCID
55.76 169
9 Characterization of early pathogenesis in the <scp>SOD</scp>… (10.1002/brb3.142)
ORCID
54.90 156
10 The burden of epilepsy and unmet need in people with focal s… (10.1002/brb3.2589)
ORCID
54.62 152
11 Reliability and reproducibility of individual differences in… (10.1002/brb3.456)
ORCID
54.55 151
12 Integration of an <scp>EEG</scp> biomarker with a clinician'… (10.1002/brb3.330)
ORCID
54.33 148
13 How cigarette smoking may increase the risk of anxiety sympt… (10.1002/brb3.137)
ORCID
54.26 147
14 The role of <scp>FGF</scp>2 in spinal cord trauma and regene… (10.1002/brb3.207)
Abstract ORCID
53.96 11
15 Polytraumatization in an adult national sample and its assoc… (10.1002/brb3.344)
Abstract ORCID
53.96 11
16 Maternal separation is associated with strain‐specific respo… (10.1002/brb3.69)
ORCID
52.42 124
17 The relationship between nerve conduction velocity and fiber… (10.1002/brb3.61)
ORCID
51.89 118
18 Cortical asymmetry in Parkinson's disease: early susceptibil… (10.1002/brb3.573)
ORCID
51.42 113
19 <scp>fMRI</scp>functional connectivity of the periaqueductal… (10.1002/brb3.579)
ORCID
51.42 113
20 Human neuronal uncoupling proteins 4 and 5 (UCP4 and UCP5):… (10.1002/brb3.55)
ORCID
51.23 111
21 Does cerebral lateralization develop? A study using function… (10.1002/brb3.56)
ORCID
51.13 110
22 The treatment of chronic depression with cognitive behaviora… (10.1002/brb3.486)
ORCID
50.32 102
23 Food‐derived hydrophilic antioxidant ergothioneine is distri… (10.1002/brb3.477)
ORCID
50.00 99
24 The adverse effects of reduced cerebral perfusion on cogniti… (10.1002/brb3.171)
ORCID
49.89 98
25 The developing human brain: age‐related changes in cortical,… (10.1002/brb3.457)
ORCID
49.89 98
26 Microglial physiopathology: how to explain the dual role of… (10.1002/brb3.51)
ORCID
49.89 98
27 Beyond vascularization: aerobic fitness is associated with N… (10.1002/brb3.30)
ORCID
49.67 96
28 Characterization of early pathogenesis in the <scp>SOD1</scp… (10.1002/brb3.143)
ORCID
49.33 93
29 Mesenchymal stem cell‐based treatments for stroke, neural tr… (10.1002/brb3.526)
ORCID
49.09 91
30 Characterizing neurocognitive impairment in young people wit… (10.1002/brb3.527)
ORCID
49.09 91
31 Fatigue in myasthenia gravis: risk factors and impact on qua… (10.1002/brb3.538)
ORCID
48.98 90
32 Nationwide hospital‐based survey of idiopathic normal pressu… (10.1002/brb3.635)
ORCID
48.98 90
33 Airborne copper exposure in school environments associated w… (10.1002/brb3.467)
ORCID
48.86 89
34 Gestational ketogenic diet programs brain structure and susc… (10.1002/brb3.300)
ORCID
48.73 88
35 Gene therapy with <scp>AAV</scp>2‐<scp>CDNF</scp> provides f… (10.1002/brb3.117)
ORCID
48.61 87
36 Executive deficits detected in mild Alzheimer's disease usin… (10.1002/brb3.28)
ORCID
48.61 87
37 Epidemic of illicit drug use, mechanisms of action/addiction… (10.1002/brb3.7)
ORCID
48.61 87
38 Deletion of galectin‐3 exacerbates microglial activation and… (10.1002/brb3.75)
ORCID
48.24 84
39 Differential roles of astrocyte and microglia in supporting… (10.1002/brb3.152)
ORCID
48.11 83
40 GPR30 activation decreases anxiety in the open field test bu… (10.1002/brb3.197)
ORCID
48.11 83
41 A postnatal peak in microglial development in the mouse hipp… (10.1002/brb3.403)
ORCID
48.11 83
42 White matter maturation of normal human fetal brain. An in v… (10.1002/brb3.17)
ORCID
47.85 81
43 Thy1‐hAPP<sup>Lond/Swe+</sup> mouse model of Alzheimer's dis… (10.1002/brb3.41)
ORCID
47.85 81
44 Functional deficits of the attentional networks in autism (10.1002/brb3.90)
ORCID
47.85 81
45 Fgf2 improves functional recovery—decreasing gliosis and inc… (10.1002/brb3.172)
ORCID
47.71 80
46 <scp>GPER</scp> expressed on microglia mediates the anti‐inf… (10.1002/brb3.449)
ORCID
47.58 79
47 Prevalence, laterality, and comorbidity of hippocampal scler… (10.1002/brb3.66)
ORCID
47.44 78
48 Role of <scp>C</scp>‐terminal negative charges and tyrosine… (10.1002/brb3.86)
ORCID
47.44 78
49 A balancing act of the brain: activations and deactivations… (10.1002/brb3.128)
ORCID
47.16 76
50 Altered resting perfusion and functional connectivity of def… (10.1002/brb3.358)
ORCID
47.16 76